Sha Fu

Requirement of bic/microRNA-155 for Normal Immune Function

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice

Chronic TLR Stimulation Controls NLRP3 Inflammasome Activation through IL-10 Mediated Regulation of NLRP3 Expression and Caspase-8 Activation

Targeting inflammasome/IL-1 pathways for cancer immunotherapy

Efficacy of epidermal growth factor receptor inhibitors versus chemotherapy as second-line treatment in advanced non-small-cell lung cancer with wild-type EGFR: A meta-analysis of randomized controlled clinical trials

Cellular and molecular mechanisms of fibrosis

Liver fibrosis

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Antisense therapeutics in oncology: current status

Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer

Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group

Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases

Pyroptosis: mechanisms and diseases

MicroRNA biogenesis pathways in cancer

Causes and consequences of microRNA dysregulation in cancer

MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy

Systemic sclerosis: a prototypic multisystem fibrotic disorder

Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis

ER Stress-induced Inflammasome Activation Contributes to Hepatic Inflammation and Steatosis

IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases

A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer

Longitudinal study of circulating protein biomarkers in inflammatory bowel disease

Endogenous microRNA sponges: evidence and controversy

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver

Common Variation in NLRP3 Is Associated With Early Death and Elevated Inflammasome Biomarkers Among Advanced HIV/TB Co-infected Patients in Botswana

IGF-I Induces Epithelial-to-Mesenchymal Transition via the IGF-IR‐Src‐MicroRNA-30a‐E-Cadherin Pathway in Nasopharyngeal Carcinoma Cells

Tr1 Cells, but Not Foxp3+ Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10–Dependent Mechanism

Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer

The Versatile Role of microRNA-30a in Human Cancer

Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis

The epithelial–mesenchymal transition: new insights in signaling, development, and disease

Knockdown of miR-214 Promotes Apoptosis and Inhibits Cell Proliferation in Nasopharyngeal Carcinoma

The Frequency and Clinical Implication of ROS1 and RET Rearrangements in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Patients

Detection of EML4-ALK Fusion Gene in Chinese Non–Small Cell Lung Cancer by Using a Sensitive Quantitative Real-Time Reverse Transcriptase PCR Technique

Inflammasome activation has an important role in the development of spontaneous colitis

High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR

MicroRNA-30a promotes invasiveness and metastasis in vitro and in vivo through epithelial–mesenchymal transition and results in poor survival of nasopharyngeal carcinoma patients